Research on inositol for PCOS support is still in early stages based on the available evidence provided here. One study is a registered clinical trial protocol — the MYPP trial — designed to test whether myo-inositol supplementation during pregnancy can reduce complications such as gestational diabetes and preterm birth specifically in women with PCOS, though no results have yet been reported since the trial is ongoing. The protocol notes that earlier research in broader populations suggested potential benefits, with post-hoc analyses hinting at stronger effects for women with PCOS in particular, but these observations remain preliminary and unconfirmed by dedicated trials. The second study linked here examines gut microbiome patterns in premature newborns and does not address inositol or PCOS, making it effectively irrelevant to this topic. Overall, the direct evidence base from the provided studies is too limited and incomplete to draw conclusions about inositol's effectiveness for PCOS support, and readers should look to the broader published literature, including completed randomized controlled trials and meta-analyses, for a more comprehensive picture.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| MYPP trial: Myo-inositol supplementation to prevent pregnancy complications i... | Other | 2025 | Supports | 90 |
| The neonatal gut microbiota: a role in the encephalopathy of prematurity | Other | 2023 | Neutral | 85 |